ELXR
vs
S
S&P TSX Composite Index (Canada)
ELXR
Over the past 12 months, ELXR has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s +22% growth.
Stocks Performance
ELXR vs S&P TSX Composite Index (Canada)
Performance Gap
ELXR vs S&P TSX Composite Index (Canada)
Performance By Year
ELXR vs S&P TSX Composite Index (Canada)
Elixxer Ltd
Glance View
Elixxer Ltd. is a cannabis investment company. The company is headquartered in Montreal, Quebec. The company went IPO on 2005-11-24. The firm invests in cannabis related businesses, which are licensed for cultivation, production and/or sale of cannabis and cannabis derived products. The company invests in cannabis industries, including nutraceutical, cosmetics, pharmaceutical, cultivation and extraction. The company is primarily focused on medical cannabis and specialty cannabis derived products in the pharmaceutical sector. The company grows and produces medical grade cannabis for global markets. The company produces and develops a range of Cannabidiol (CBD) cosmetics and natural wellness CBD products. The company also invests in facilities that allows cultivation, extraction and production of legal products. Its brands include Viridi, Easyjoint, Freia, Little Green Pharma (LGP) and One Premium Cannabis. The firm has investments in cannabis companies in Australia, Canada, Switzerland, Italy and Jamaica. Its subsidiaries include LGC Finance Limited, LGC Capital EU OU and LGC Capital Spain S.L.